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Life and Death Signaling in Epidermis: Following a Planned Cell Death Pathway Involving a Trail That Does
Not Lead to Skin Cancer
Creation of a cutaneous barrier requires production of the stratum
corneum. Ironically, the vitality of skin depends on the properly
regulated formation and function of dead keratinocytes (KC) in the
exquisitely thin outermost layers of epidermis. The death of the
corneocytes must be delayed until the KC undergo terminal
differentiation. We recently coined the term ``planned cell death
pathway'' to signify the temporal and spatially coordinated reactions
that are operative in the epidermis giving rise to the orderly process
of corneogenesis. As this concept implies, if there is premature
keratinocyte cell death prior to terminal differentiation, this
portends disastrous consequences for the epidermis; not only
altering epidermopoiesis, but also the barrier function of skin. Such
abnormalities render the patient highly susceptible to life-
threatening infections. Whereas it is intuitively obvious that
maintenance of a physiologic epidermal thickness requires a balance
between cell proliferation and cell death, the precise biochemical
mechanisms that govern this regulated balancing act are not known
at this time. For example, we do not know if the death of KC
under physiologic conditions is initiated by death ligands/receptors
at the plasma membrane, or triggered by a primary event in the
mitochondria or nucleus. Moreover, it is unknown if this
specialized form of cell death requires speci®c caspases, or other
effector enzymes. How can the entire collection of viable KC in
the stratum granulosum within one cell layer have its organelles,
not to mention its nuclear contents, including all of the DNA
completely digested without provoking an in¯ammatory reaction,
and creating such a highly organized structure of cross-linked
lamellar bilayers on the outside despite the massive intracellular
turmoil just a few microns away? These are just a few of the
unanswered questions facing investigative skin biologists.
As a self-renewing tissue, the continual entry of transiently
amplifying cells derived from stem cell precursors cannot be
permitted to propagate unchecked. The initial cell cycle-mediated
growth arrest, followed by early/late differentiation, with ®nal
induction of cell death and desquamation, represent the critical
determinants that serve a subtractive function in normal epidermis
to preserve homeostasis. On the one hand, imbuing KC with
various cell survival genes provides a defense against premature
apoptosis, or other forms of cell death, prior to terminal
differentiation. Especially in skin that is subjected to a wide variety
of potentially harmful or toxic stimuli (i.e., ultraviolet/ionizing
radiation, chemical irritants, infectious organisms), KC have many
molecular tools at their disposal to prevent or minimize cell death.
On the other hand, if there are excessive pro-survival gene
products operative in KC that can interfere with terminal
differentiation and corneogenesis, there may also be pathologic
consequences such as thickened skin with altered barrier properties
(i.e., psoriatic plaques), or accumulation of KC with genetic
abnormalities that result in skin cancer.
In this issue, Bachmann et al (p. 59) explore the role of several
mediators of KC cell death with respect to the evolution of actinic
keratoses (AK) and formation of squamous cell carcinoma (SCC).
Speci®cally, they focus on the apoptotic response of KC involving
sunlight, and two increasingly prominent members of the tumor
necrosis superfamily CD95L and TRAIL. Both of these ligands can
trigger cell death by engaging speci®c receptors on the surface of
target cells. For CD95L, the ligand-receptor system is relatively
straightforward; but the TRAIL pathway is more complex, as there
are receptors that mediate cell death (i.e., TRAIL-R1 and -R2),
but there are also so-called ``decoy'' receptors (i.e., TRAIL-R3 and
-R4). These latter receptors can bind TRAIL, but rather than
provoking cell death may either produce a null event, or signal a
potentially important survival pathway involving NF-kB activa-
tion. There are several noteworthy observations contained within
the Bachmann et al report. First, these investigators document the
presence of CD95 and CD95L, as well as TRAIL and its receptors
in skin. Whereas several previous groups have dissected out the
epidermal location and change in expression for CD95/CD95L
before and after UV-irradiation in mice and human subjects, this is
one of the initial publications identifying the TRAIL family
members in normal and diseased human skin. The nonrandom
distribution patterns in normal skin for TRAIL and its death/decoy
receptors is intriguing. Even though investigations into apoptotic
processes are usually centered around various pathologic states (i.e.,
autoimmunity or malignancy), the presence of TRAIL and its
receptors in normal skin appears to be strategically placed to also
subserve a physiologic function, such as producing the stratum
corneum to ensure the structural integrity of the epidermis. For
example, the basal layers of epidermis that contain stem cells and
transiently amplifying cells, contain high levels of the cell survival
protein FLIP, and low or absent levels of the death receptors CD95
and TRAIL-R1 and -R2. Moreover, the decoy receptor TRAIL-
R3 is strongly expressed in the basal layer. As one moves upward
and outward in the epidermis, there are higher levels of the death
receptors, TRAIL-R1 and -R2, accompanied by diminished to
absent levels of the decoy receptors. Given the concomitant
presence of both death ligands ± CD95L and TRAIL ± throughout
the epidermis, and veri®cation that they are expressed as
functionally active at inducing apoptosis in various immunocytes
ex vivo, it is tantalizing to speculate that these ligands also contribute
to KC cell death leading to formation of stratum corneum. More
de®nitive experiments are warranted to con®rm this speculation,
however, but it may be true that the constitutive expression and
strategic location of the CD95L and TRAIL components are
fundamentally important molecular determinants of the structural
integrity of human epidermis. Secondly, response of KC within
human skin to UV irradiation is examined with respect to these
death ligands/receptors. UV light presents several challenges for the
epidermis ± it can induce DNA damage giving rise to premalignant
and malignant cells with altered differentiation and growth
characteristics. UV light can also directly induce premature
apoptosis of KC. In both these scenarios barrier function is
perturbed, and understanding the molecular mechanism underlying
the UV light response of KC may shed new light on ®nding better
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methods to treat the many skin pathologies that arise following
excessive solar exposure. As Bachmann et al discovered, UV light
exposure directly in¯uences KC expression of the aforementioned
death ligands/receptors. Speci®cally they observed an initial
increase in KC CD95L expression, followed by a decrease,
accompanied by an increase in CD95 expression. Expression of
TRAIL and both death/decoy receptors tended to diminish in
acutely irradiated skin. Interestingly, chronically UV-exposed skin
of two individuals with heavily sun-tanned areas revealed similar
changes. Whereas it is dif®cult to draw de®nitive conclusions based
on a single individual's acute response to UV light, or from two
subjects with tanned skin, further studies are warranted to more
precisely determine speci®c contributions of these TNF members'
role in the apoptotic response of epidermal KC to UV light. It is
likely that there will be cross-talk between p53, NF-kB, and the
expression of various death ligands and death/decoy receptors that
contribute to the life and death signaling responses in skin.
Thirdly, the expression of these death mediators is examined in
12 samples of AK and four cases of SCC. Whereas the precancerous
AK failed to express CD95L, the invasive SCC strongly and
diffusely were positive for CD95L, which was associated with an
absence of CD95 by the tumor cells. The authors suggest that not
only can the cancer cells avoid killing themselves, or their adjacent
counterparts (they fail to express CD95), but the malignant cells
could launch a pre-emptive strike by expressing CD95L against
tumor in®ltrating immunocytes that do express CD95. The
malignant cells also expressed TRAIL and FLIP, which may
operate in a similar fashion to preserve the viability of the tumor
cell and providing it with a molecular sword to fend off tumor-
seeking cytotoxic T cells. Once again, the transformed cells protect
themselves, by down-modulating the TRAIL death receptors, just
as they eliminated CD95 expression rendering them immune to
killing via these important mediators of apoptosis in skin.
Taken together, these three observations add valuable data to the
literature and advance our understanding of the role speci®c death
ligands/receptors play in both normal and pathologic skin
conditions. Following this line of inquiry may reveal new insights
into immune privilege, autoimmunity, and carcinogenesis invol-
ving skin. Finding methods to selectively kill premalignant or
transformed cells in the epidermis and/or dermis, but at the same
time avoiding triggering premature apoptosis of normal cells,
should be possible as we learn more about these mediators of life
and death signaling in skin. Interestingly, in a completely different
system involving retinoic acid-induced apoptosis of leukemia cells,
Altucci et al (Nat Med 7:680±686, 2001) noted a key role for
TRAIL in which an early and late differentiation program was
followed by a post-maturation apoptotic event mediated by
TRAIL. It will also be important to try and ®nd methods to avoid
premature apoptosis of normal KC without necessarily enhancing
the survival of premalignant or transformed cells in the skin.
Sensing and Killing Bacteria by Skin: Innate Immune Defense System: Good and Bad News
The primary function of human skin is to produce a protective coat
preventing excessive water loss (i.e., dehydration), and shielding
against an infectious onslaught from a myriad of lethal bacteria,
fungi, and viruses. This no easy task as the skin of terrestial
inhabitants such as ourselves are constantly exposed to mechanical
stress, thermal variations, changes in relative humidity, solar and
ionizing radiation, as well as chemical irritants and toxins. The
specialized barrier function of skin is accomplished by formation of
the stratum corneum in the outermost layers of epidermis, when
keratinocytes undergo terminal differentiation and cell death.
Despite the deceptively simple light microscopic appearance and
thinness of the stratum corneum, it harbors several elegant,
complex, and dynamic processes designed to detect and then
destroy potentially harmful bacteria. Not only does the lipid rich
stratum corneum form a physical shield amongst the mummi®ed
and anucleated cells, but there is also an ``acid mantle'' produced by
energy requiring mechanisms that can inhibit colonization by
certain pathogenic bacteria such as Staphylococcus aureus. As reported
by Fluhr et al (p. 44), generation of an acidic pH by free fatty acids
regulates stratum corneum acidi®cation and functional integrity.
But there are other innate defense systems in the epidermis that
contribute to this biologic ``Saran Wrap'' as demonstrated by
Durschner et al (p. 91). Besides the physical barriers, including
acidic pH, lipids, and various hydrolytic enzymes, epidermal
keratinocytes also produce a wide variety of antibacterial peptides,
including a-defensins, b-defensins, and cathelicidins. In general,
this small cationic peptide-based defense system is better at
destroying certain types of bacteria such as group A Streptococcus,
but are relatively ineffective against Staph. aureus. Given the
increasing incidence of antibiotic resistant strains of Staph. aureus,
and the role Staph. aureus plays in several common and chronic skin
diseases such as atopic dermatitis and psoriasis, further research to
hunt for methods to bolster the innate immune response against
Staph aureus are certainly warranted. We should not just think about
®nding our way to the local pharmacy for a new type of synthetic
antibiotic, but scratching beneath the surface of our own skin may
yields new insights from this evolutionarily ancient component of
our innate defense system into treatment strategies to ®ght bacterial
infections.
One way to search for new ways of treating cutaneous infections
is to probe the molecular and cellular response a healthy individual
mounts when the structural shield is compromised. Previous studies
of murine and human subjects revealed that following perturbation
of the barrier function, there is a rapid and prominent release of
cytokines by epidermal keratinocytes, including TNF-a. This
cytokine is of primary importance and can promote barrier repair.
TNF-a initiates a cytokine cascade designed to attract and retain
acute in¯ammatory cells such as neutrophils and monocytes, by
releasing chemotactic polypeptides and expressing adhesion
molecules. In addition, as Dorschner et al demonstrate, cutaneous
injury also induces release of the cathelicidin antimicrobial peptides
to bolster the initial keratinocyte-led battle against bacteria in the
environment. Under most conditions, this rapid multimolecular
response is highly effective at promoting wound repair and
restoring cutaneous homeostasis. These and other studies have
clearly established that we should not regard keratinocytes as only
inert or passive contributors to cutaneous immunity, but as versatile
active initiators and dynamic participants of the skin's immune
system. Although this is the good news for the vast majority of
healthy individuals, there is also some bad news that relates to the
cutaneous innate immune response. The bad news is that some
genetically based diseases are characterized by abnormal responses
to skin infections. For example, patients with atopic dermatitis are
frequently and heavily colonized by Staph. aureus. Not only is it
possible that the inability of the host immune system to eradicate
Staph. aureus is a critical contributor to the dermatologic problem,
but the associated in¯ammatory reaction may actually drive or
exacerbate the skin pathology by enhancing attachment of Staph.
aureus to the keratinocytes (Cho et al, J Invest Dermatol 116:658±
663, 2001), thus creating a vicious cycle. Another example of
viewing the innate immune system as a foe rather than a friend is
psoriasis. In this disease, there is actually an extremely low
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